Related references
Note: Only part of the references are listed.Use of multidimensional composite scores in rheumatology: parsimony versus subtlety
Robert B. M. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
DAPSA versus cDAPSA: Do we need to use CRP?
Rafaela Silva Guimaraes Goncalves et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
Dylan McGagh et al.
RHEUMATOLOGY (2020)
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study
Laura C. Coates et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naive to biological disease-modifying antirheumatic drug: final results by week 52
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
Peter Nash et al.
RHEUMATOLOGY AND THERAPY (2020)
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis
Ruben Queiro et al.
JOURNAL OF RHEUMATOLOGY (2019)
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries
Clemence Gorlier et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Quality of life in psoriatic arthritis
Tania Gudu et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Considerations for the definition of remission criteria in psoriatic arthritis
Philip J. Mease et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis
Laura C. Coates et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Disease activity assessment in patients with psoriatic arthritis
Andreas Kerschbaumer et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2018)
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease
Philip Helliwell et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
Peter Nash et al.
RHEUMATOLOGY AND THERAPY (2018)
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression
D. Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Psoriatic Arthritis
Christopher T. Ritchlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
P. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Dafna Gladman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The psychosocial burden of psoriatic arthritis
M. Elaine Husni et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
The Changing Face of Clinical Trials in Psoriatic Arthritis
Alexis Ogdie et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score
Monika M. Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments
Laura C. Coates et al.
JOURNAL OF RHEUMATOLOGY (2016)
The definition of remission in psoriatic arthritis: can this be accurate without assessment of multiple domains?
Philip S. Helliwell et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Defining remission and treatment success using the DAPSA score: response to letter by Helliwell and Coates
Monika M. Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The Epidemiology of Psoriatic Arthritis
Alexis Ogdie et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2015)
]Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis
K. Migita et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria
Hernan Maldonado Ficco et al.
CLINICAL RHEUMATOLOGY (2014)
Reduced Joint Counts Misclassify Patients With Oligoarticular Psoriatic Arthritis and Miss Significant Numbers of Patients With Active Disease
Laura C. Coates et al.
ARTHRITIS AND RHEUMATISM (2013)
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Philip J. Mease et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone
Cheryl F. Rosen et al.
RHEUMATOLOGY (2012)
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
L. C. Coates et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis
Monika Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Validation of Minimal Disease Activity Criteria for Psoriatic Arthritis Using Interventional Trial Data
Laura C. Coates et al.
ARTHRITIS CARE & RESEARCH (2010)
Share Paper
